BLT-1 是一种硫半碳杂铜螯合剂，选择性清道夫受体 B1 型 (SR-BI) 抑制剂。BLT-1 抑制 SR-BI 介导的脂质在高密度脂蛋白 (HDL) 和细胞之间的转移。BLT-1 是一种有效的 HCV 进入抑制剂。

BLT-1, a thiosemicarbazone copper chelator, is a selective scavenger receptor B, type 1 (SR-BI) inhibitor. BLT-1 inhibits the transfer of lipids between high-density lipoproteins (HDL) and cells mediated by SR-BI. BLT-1 is a potent HCV entry inhibitor.

Solid

BLT-1 has IC50s of 60 and 110 nM for cellular DiI-HDL and [H]CE-HDL uptake in ldlA[mSR-BI] cells.
BLT-1 has an IC50 of 0.96 μM for the HCV entry in Huh 7.5.1 cells.
BLT-1 (50 μM; 3 hours) does not induce general defects in clathrin-dependent and -independent intracellular membrane trafficking in HeLa, BSC-1 cells.
BLT-1 can inhibit SR-BI-dependent selective uptake of [H]CE from [H]CE-HDL by mSR-BI-t1-containing liposomes in cells (IC50=0.057 μM) and liposomes (IC50=0.098 μM) .
has not independently confirmed the accuracy of these methods. They are for reference only.

Room temperature in continental US; may vary elsewhere.

Powder -20°C 3 years；4°C 2 years

[1]. Nieland TJ, et al. Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptorSR-BI. Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15422-7.
[2]. Nieland TJ, et al. Identification of the molecular target of small molecule inhibitors of HDL receptor SR-BI activity. Biochemistry. 2008 Jan 8;47(1):460-72.

In Vitro: DMSO : 41.67 mg/mL (172.62 mM; Need ultrasonic)配制储备液